Spero Therapeutics (SPRO) Q4 2023 Earnings

13MarConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-0.34
0.09
0.53
0.96

Details

Expected EPS
-0.1
Actual EPS
0.96
Surprise EPS
1.06
Surprise Percent
+1,060%

Description

Spero Therapeutics (SPRO) has reported earnings of 0.96 per share for Q4 2023.

0 Comments

Share your thoughts